Lovelace Biomedical Research InstituteJanuary 27, 2026

FDA 483 - Lovelace Biomedical Research Institute - January 27, 2026

FDA 483 for Lovelace Biomedical Research Institute on January 27, 2026. Product: drugs. Access full analysis and detailed observations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA 483 for Lovelace Biomedical Research Institute on January 27, 2026. Product: drugs. Access full analysis and detailed observations.

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Lovelace Biomedical Research Institute

Inspection Date

January 27, 2026

Product Type

drugs

Office

Division of Human and Animal Food Operations - West IV

People

ID: 06275513-06c6-4093-ab6e-d49bde789606

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox